In a letter to baseball commissioner Bud Selig and players representative Donald Fehr, Chairman Davis and Ranking Member Waxman raise questions about baseball’s new steroid policy, including its penalties, scope, and implementation.
Rep. Waxman reveals that Administration officials, acting at the request of Halliburton, redacted a Pentagon report to conceal more than $100 million in fuel overcharges from international auditors overseeing the Development Fund for Iraq.
Reps. Waxman and Dingell reveal that Defense Department auditors have determined, in a report withheld from Congress, that Halliburton overcharged by more than $100 million under its no-bid Iraq oil contract.
Chairman Davis and Rep. Waxman detail the basis for the Committee's investigation into steroid use and reject the premise that Major League Baseball and its players are above responsible scrutiny.
Rep. Waxman and Sen. Collins ask the HHS Inspector General and the Administrator of the Center for Medicare and Medicaid Services to halt an initiative to cut off federal funding for the medical treatment of children with severe mental illness.
Rep. Waxman releases a new GAO study that shows that the federal agency responsible for Medicaid has failed to ensure that the program get the "best possible" prices from prescription drug manufacturers, as required under law.
Chairman Davis and Rep. Waxman write Administration officials and GAO about the increasing number of no-bid federal contracts awarded to Alaska Native Corporations under special contracting provisions.
In a letter to Secretary Rumsfeld, Rep. Waxman asks for details of the Defense Department's contracts with Engineered Support Systems, Inc., on whose board William H.T. Bush, the President's uncle, sits. An Undersecretary of Defense has said the contracts "appear to have anomalies in them."
Reps. Waxman, Miller, and DeLauro write to HHS about a recent report that the agency continues to use prepackaged video news releases as part of the Department's public relations efforts.
In a letter calling for a congressional investigation, Rep. Waxman provides examples of how proliferating information designations such as "sensitive but unclassified" have been used to block the release of important government records.
A new report released by Reps. Waxman and other senior members of Congress details how the Social Security Administration has systematically altered its public communications.
In a letter to Chairman Davis, Rep. Waxman asks for congressional hearings into the allegations of steroid use in Major League Baseball and the adequacy of the league's response.
Reps. Waxman and Meehan write to Attorney General Gonzales to express their support for the Justice Department's aggressive pursuit of the landmark case against the tobacco industry.
The Comptroller General writes to all executive branch agency heads to advise them of the restrictions on spending for "publicity and propaganda," specifically noting the GAO's finding that some prepackaged news stories are illegal covert propaganda.
In letters to Secretary of State Rice and USAID Administrator Natsios, Reps. Waxman and Cummings clarify the International Narcotics Control Board's position on the efficacy of needle exchange programs. Chairmen Davis and Souder had mischaracterized the report in previous correspondence.
Rep. Waxman asks for a full explanation of the role of Ambassador Dick Jones, Secretary of State Rice's choice to head U.S. Iraq policy, in the steering of a lucrative fuel contract to an obscure Kuwaiti company.
Rep. Waxman and 18 other member of Congress urge the Department of Labor to continue the National Agricultural Workers Survey, which provides essential information on employment, immigration, health, public benefits, education, wages, and income.
Reps. Waxman and Gordon introduce H.R. 839, legislation to protect federal science from political interference. The bill includes bars on manipulating science, suppressing research, and using political litmus tests to appoint members of scientific advisory committees.
Rep. Waxman expresses concerns to FDA Acting Commissioner Dr. Lester Crawford that budget cuts proposed by the President will reduce the number of FDA employees and hamper already-faltering enforcement efforts.
There has been a sharp decline in FDA enforcement actions against misleading drug advertisements and violations of manufacturing standards by biologic drug companies since Dr. Lestor Crawford was appointed as Acting Commissioner in early 2002.
A politically well connected organization that promotes abstinence education has received a major federal grant under the President’s AIDS program despite its proposal having been rated "not suitable for funding" by an independent review panel.
At a Senate Democratic Policy Committee hearing, a former Coalition Provisional Authority official and other whistleblowers testify on the waste, fraud, and abuse of Iraqi funds under the stewardship of the Bush Administration.
Reps. Waxman and Maloney ask for hearings on whether political considerations caused the Administration to delay release of findings by the 9/11 Commission about pre-attack warnings.
Reps. Waxman and Rahall write Interior Secretary Norton about new survey results that describe pervasive politicization of FWS’s scientific mission.
Rep. Waxman, Sen. Akaka and Rep. Danny Davis express serious concerns about a Defense Department plan to give higher raises to political appointees than to career employees.
Displaying Items 751 to 775 of 1318:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53]